Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications

• Published in: AAPS PharmSciTech Vol. 20; no. 8; p. 313
• Main Author: Singh, Brahma N.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 16.09.2019
• Subjects: Biochemistry; Biomedical and Life Sciences; Biomedicine; Biotechnology; Dosage Forms; Drug Compounding; Drug Design; Drug Industry - methods; Drug Industry - standards; Drug Packaging - methods; Drug Packaging - standards; Humans; Pharmacology/Toxicology; Pharmacy; Quality Control; Review Article; process analytical technology (PAT); design of experiments (DOEs); quality by design (QbD); statistical optimization; design space; mathematical models
• ISSN: 1530-9932; 1530-9932
• DOI: 10.1208/s12249-019-1515-8

An integrated approach based on QbD and PAT provides a systematic and innovative framework for product development, manufacturing, and quality risk management. In this context, the significance of the outcome of design of experiments (DOEs) to the selection of the product design, robust commercial manufacturing process, design space, and overall control strategy remains vital for the success of a drug product throughout its life cycle. This paper aims at discussing selected recent DOE case studies conducted during QbD-based and integrated QbD/PAT-based development of solid oral formulations and process improvement studies. The main focus of this paper is to highlight the rationales and importance of design selection during development and applications of mathematical models and statistical tools in analyzing DOE and PAT data for developing a design space, control strategy, and improved process monitoring. A total of 25 case studies (includes 9 PAT application studies) have been discussed in this paper which cover 11 manufacturing processes commonly utilized for solid dosage forms. Two case studies relevant to selection of packaging design for solid dosage forms are also briefly discussed to complete the scope. Overall, for a successful modern QbD approach, it is highly important that DOEs are conducted and analyzed in a logical sequence which involves designs that are phase-appropriate and quality-driven and facilitate both statistical and chemometric thinking at each development stage. This approach can result into higher regulatory flexibility along with lower economic burden during life cycle of a product, irrespective of regulatory path used (NDA or ANDA).